Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator

Respiratory Research

Volumn 7, Issue , 2006, Pages

  Tirkos, Sam ^a   Newbigging, Susan ^b   Nguyen, Van ^a   Keet, Mary ^c,d   Ackerley, Cameron ^e   Kent, Geraldine ^e   Rozmahel, Richard F ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; MESSENGER RNA; PROTEIN S 100; PROTEIN S100A8; PROTEIN S100A9; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; CALGRANULIN A; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; S100A8 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONGENIC STRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CYSTIC FIBROSIS; DISEASE COURSE; GENE EXPRESSION REGULATION; HEREDITY; IN SITU HYBRIDIZATION; LUNG PARENCHYMA; MOUSE; MOUSE STRAIN; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RANK SUM TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; DEFICIENCY; DISEASE MODEL; GENETICS; LUNG; METABOLISM; PATHOLOGY;

ANIMALS; CALGRANULIN A; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; LUNG; MICE; MICE, CONGENIC; MICE, INBRED BALB C; MICE, INBRED C57BL; S100 PROTEINS;

EID: 33646249416     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-51     Document Type: Article

References (91)

1. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan J, Tsui L-C, Collins FS: Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989, 245(4922):1059-1065.
2. Riordan JR, Rommens J, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J-L, Drumm M, Iannuzzi M, Collins SF, Tsui L-C: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245(4922):1066-1073.
3. Welsh MJ, Ramsey BW, Accurso FJ, Cutting GR, (ed): Cystic fibrosis. Eigth edition. New York, NY: McGraw-Hill Inc; 2001.
4. Cystic Fibrosis Mutation Database [http://www.genet.sickkids.on.ca/ cgi-bin/WebObjects/MUTATION]
5. Muhlebach MS, Stewart PW, Leigh MW, Noah TL: Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999, 160(1):186-191.
6. Konstan MW, Hilliard KA, Norvell TM, Berger M: Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994, 150(2):448-454.
7. Konstan MW, Berger M: Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 1997, 24(2):137-142.
8. Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R: The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995, 20(2):63-70.
9. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW: Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995, 151(4):1075-1082.
10. Bonfield TL, Konstan MW, Berger M: Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 1999, 104(1):72-78.
11. Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M: Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995, 13(3):257-261.
12. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M: Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995, 152(6 Pt 1):2111-2118.
13. Massengale AR, Quinn F Jr, Yankaskas J, Weissman D, McClellan WT, Cuff C, Aronoff SC: Reduced interleukin-8 production by cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 1999, 20(5):1073-1080.
14. Stecenko AA, King G, Torii K, Breyer RM, Dworski R, Blackwell TS, Christman JW, Brigham KL: Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells. Inflammation 2001, 25(3):145-155.
15. Tabary O, Zahm JM, Hinnrasky J, Couetil JP, Cornillet P, Guenounou M, Gaillard D, Puchelle E, Jacquot J: Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol 1998, 153(3):921-930.
16. Venkatakrishnan A, Stecenko AA, King G, Blackwell TR, Brigham KL, Christman JW, Blackwell TS: Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 2000, 23(3):396-403.
17. Doring G, Worlitzsch D: Inflammation in cystic fibrosis and its management. Paediatr Respir Rev 2000, 1(2):101-106.
18. Kammouni W, Figarella C, Marchand S, Merten M: Altered cytokine production by cystic fibrosis tracheal gland serous cells. Infect Immun 1997, 65(12):5176-5183.
19. Kube D, Sontich U, Fletcher D, Davis PB: Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am J Physiol Lung Cell Mol Physiol 2001, 280(3):L493-502.
20. Schwiebert LM, Estell K, Propst SM: Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression. Am J Physiol 1999, 276(3 Pt 1):C700-710.
21. Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW: Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 2001, 32(5):356-366.
22. Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD: Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Bmj 1995, 310(6994):1571-1572.
23. Grubb BR, Paradiso AM, Boucher RC: Anomalies in ion transport in CF mouse tracheal epithelium. Am J Physiol 1994.
24. Grubb BR, Vick RN, Boucher RC: Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl-secretion in nasal epithelia of CF mice. Am J Physiol 1994.
25. Scholte BJ, Davidson DJ, Wilke M, De Jonge HR: Animal models of cystic fibrosis. J Cyst Fibros 2004, 3(Suppl 2):183-190.
26. Kent G, Iles R, Bear CE, Huan LJ, Griesenbach U, McKerlie C, Frndova H, Ackerley C, Gosselin D, Radzioch D, O'Brodovich H, Tsui LC, Buchwald M, Tanswell AK: Lung disease in mice with cystic fibrosis. J Clin Invest 1997, 100(12):3060-3069.
27. Haston CK, McKerlie C, Newbigging S, Corey M, Rozmahel R, Tsui LC: Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice. Mamm Genome 2002, 13(11):605-613.
28. Durie PR, Kent G, Phillips MJ, Ackerley CA: Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am J Pathol 2004, 164(4):1481-1493.
29. Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, Ferkol T: Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 1997, 100(11):2810-2815.
30. Cowley EA, Wang CG, Gosselin D, Radzioch D, Eidelman DH: Mucociliary clearance in cystic fibrosis knockout mice infected with Pseudomonas aeruginosa. Eur Respir J 1997, 10(10):2312-2318.
31. Thomas GR, Costelloe EA, Lunn DP, Stacey KJ, Delaney SJ, Passey R, McGlinn EC, McMorran BJ, Ahadizadeh A, Geczy CL, Wainwright BJ, Hume DA: G551D cystic fibrosis mice exhibit abnormal regulation of inflammation in lungs and macrophages. J Immunol 2000, 164(7):3870-3877.
32. Davidson DJ, Dorin JR, McLachlan G, Ranaldi V, Lamb D, Doherty C, Govan J, Porteous DJ: Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat Genet 1995, 9(4):351-357.
33. Coleman FT, Mueschenborn S, Meluleni G, Ray C, Carey VJ, Vargas SO, Cannon CL, Ausubel FM, Pier GB: Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Proc Natl Acad Sci U S A 2003, 100(4):1949-1954.
34. McMorran BJ, Palmer JS, Lunn DP, Oceandy D, Costelloe EO, Thomas GR, Hume DA, Wainwright BJ: G551D CF mice display an abnormal host response and have impaired clearance of Pseudomonas lung disease. Am J Physiol Lung Cell Mol Physiol 2001, 281(3):L740-747.
35. Sajjan U, Thanassoulis G, Cherapanov V, Lu A, Sjolin C, Steer B, Wu YJ, Rotstein OD, Kent G, McKerlie C, Forstner J, Downey GP: Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice. Infect Immun 2001, 69(8):5138-5150.
36. Guilbault C, Martin P, Houle D, Boghdady ML, Guiot MC, Marion D, Radzioch D: Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique. Lab Anim 2005, 39(3):336-352.
37. Stotland PK, Radzioch D, Stevenson MM: Mouse models of chronic lung infection with pseudomonas aeruginosa: models for the study of cystic fibrosis. Pediatr Pulmonol 2000, 30(5):413-424.
38. Xu Y, Clark JC, Aronow BJ, Dey CR, Liu C, Wooldridge JL, Whitsett JA: Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency. J Biol Chem 2003, 278(9):7674-7682.
39. Bensalem N, Ventura AP, Vallee B, Lipecka J, Tondelier D, Davezac N, Dos Santos A, Perretti M, Fajac A, Sermet-Gaudelus I, Renouil M, Lesure JF, Halgand F, Laprevote O, Edelman A: Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients. Mol Cell Proteomics 2005, 4(10):1591-1601.
40. Saadane A, Soltys J, Berger M: Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice. J Allergy Clin Immunol 2005, 115(2):405-411.
41. Guilbault C, Novak JP, Martin P, Boghdady ML, Saeed Z, Guiot MC, Hudson TJ, Radzioch D: Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared to their littermate controls. Physiol Genomics 2006.
42. Kent G, Ackerley C: Personal communication. 2003.
43. Tirkos S, Chung C, Fang I, Kent G, Rozmahel R: Investigation of S100A8 as a modifier of lung disease in CF mice. Pediatr Pulmonol 2001, 32(S22):A299.
44. Nacken W, Roth J, Sorg C, Kerkhoff C: S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 2003, 60(6):569-580.
45. Passey RJ, Xu K, Hume DA, Geczy CL: S100A8: emerging functions and regulation. J Leukoc Biol 1999, 66(4):549-556.
46. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA: Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003, 170(6):3233-3242.
47. Roth J, Vogl T, Sorg C, Sunderkotter C: Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 2003, 24(4):155-158.
48. Thorey IS, Roth J, Regenbogen J, Halle JP, Bittner M, Vogl T, Kaesler S, Bugnon P, Reitmaier B, Durka S, Graf A, Wockner M, Rieger N, Konstantinow A, Wolf E, Goppelt A, Werner S: The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J Biol Chem 2001, 276(38):35818-35825.
49. Yui S, Nakatani Y, Mikami M: Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 2003, 26(6):753-760.
50. Foell D, Frosch M, Sorg C, Roth J: Phagocyte-specific calciumbinding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 2004, 344(1-2):37-51.
51. Striz I, Trebichavsky I: Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004, 53(3):245-253.
52. Haston CK, Tsui LC: Loci of intestinal distress in cystic fibrosis knockout mice. Physiol Genomics 2003, 12(2):79-84.
53. Haston CK, Corey M, Tsui LC: Mapping of genetic factors influencing the weight of cystic fibrosis knockout mice. Mamm Genome 2002, 13(11):614-618.
54. Kent G, Oliver M, Foskett JK, Frndova H, Durie P, Forstner J, Forstner GG, Riordan JR, Percy D, Buchwald M: Phenotypic abnormalities in long-term surviving cystic fibrosis mice. Pediatr Res 1996, 40(2):233-241.
55. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16(3):1215.
56. Ravasi T, Hsu K, Goyette J, Schroder K, Yang Z, Rahimi F, Miranda LP, Alewood PF, Hume DA, Geczy C: Probing the S100 protein family through genomic and functional analysis. Genomics 2004, 84(1):10-22.
57. Edgeworth J, Gorman M, Bennett R, Freemont P, Hogg N: Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem 1991, 266(12):7706-7713.
58. Hessian PA, Edgeworth J, Hogg N: MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J Leukoc Biol 1993, 53(2):197-204.
59. Heizmann CW: The multifunctional S100 protein family. Methods Mol Biol 2002, 172:69-80.
60. Hobbs JA, May R, Tanousis K, McNeill E, Mathies M, Gebhardt C, Henderson R, Robinson MJ, Hogg N: Myeloid cell function in MRP-14 (S100A9) null mice. Mol Cell Biol 2003, 23(7):2564-2576.
61. Kerkhoff C, Klempt M, Kaever V, Sorg C: The two calcium-binding proteins, S100A8 and S100A9, are involved in the metabolism of arachidonic acid in human neutrophils. J Biol Chem 1999, 274(46):32672-32679.
62. Kerkhoff C, Sorg C, Tandon NN, Nacken W: Interaction of S100A8/ S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. Biochemistry 2001, 40(1):241-248.
63. Devery JM, King NJ, Geczy CL: Acute inflammatory activity of the S100 protein CP-10. Activation of neutrophils in vivo and in vitro. J Immunol 1994, 152(4):1888-1897.
64. Graf JM, Smith CW, Mariscalco MM: Contribution of LFA-1 and Mac-1 to CD18-dependent neutrophil emigration in a neonatal rabbit model. J Appl Physiol 1996, 80(6):1984-1992.
65. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC: Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 1989, 83(6):2008-2017.
66. Eue I, Pietz B, Storck J, Klempt M, Sorg C: Transendothelial migration of 27E10+ human monocytes. Int Immunol 2000, 12(11):1593-1604.
67. Roth J, Burwinkel F, van den Bos C, Goebeler M, Vollmer E, Sorg C: MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 1993, 82(6):1875-1883.
68. Mahnke K, Bhardwaj R, Sorg C: Heterodimers of the calcium-binding proteins MRP8 and MRP14 are expressed on the surface of human monocytes upon adherence to fibronectin and collagen. Relation to TNF-alpha, IL-6, and superoxide production. J Leukoc Biol 1995, 57(1):63-71.
69. Newton RA, Hogg N: The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 1998, 160(3):1427-1435.
70. Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, Tessier PA: Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 2003, 171(5):2602-2609.
71. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK: Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990, 336(8718):763-765.
72. Sohnle PG, Collins-Lech C, Wiessner JH: Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils. J Infect Dis 1991, 163(1):187-192.
73. Santhanagopalan V, Hahn BL, Sohnle PG: Resistance of zinc-supplemented Candida albicans cells to the growth inhibitory effect of calprotectin. J Infect Dis 1995, 171(5):1289-1294.
74. Brandtzaeg P, Gabrielsen TO, Dale I, Muller F, Steinbakk M, Fagerhol MK: The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol 1995, 371A:201-206.
75. Sohnle PG, Hahn BL, Santhanagopalan V: Inhibition of Candida albicans growth by calprotectin in the absence of direct contact with the organisms. J Infect Dis 1996, 174(6):1369-1372.
76. Loomans HJ, Hahn BL, Li QQ, Phadnis SH, Sohnle PG: Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. J Infect Dis 1998, 177(3):812-814.
77. Sohnle PG, Hunter MJ, Hahn B, Chazin WJ: Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J Infect Dis 2000, 182(4):1272-1275.
78. Nisapakultorn K, Ross KF, Herzberg MC: Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis. Infect Immun 2001, 69(7):4242-4247.
79. Nisapakultorn K, Ross KF, Herzberg MC: Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect Immun 2001, 69(6):3692-3696.
80. Passey RJ, Williams E, Lichanska AM, Wells C, Hu S, Geczy CL, Little MH, Hume DA: A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo. J Immunol 1999, 163(4):2209-2216.
81. Pechkovsky DV, Zalutskaya OM, Ivanov GI, Misuno NI: Calprotectin (MRP8/ 14 protein complex) release during mycobacterial infection in vitro and in vivo. FEMS Immunol Med Microbiol 2000, 29(1):27-33.
82. Barthe C, Carrere J, Figarella C, Guy-Crotte O: Isolation of the "cystic fibrosis protein" from serum. Clin Chem 1989, 35(9):1901-1905.
83. Barthe C, Figarella C, Carrere J, Guy CO: Identification of 'cystic fibrosis protein' as a complex of two calcium-binding proteins present in human cells of myeloid origin. Biochim Biophys Acta 1991, 1096(2):175-177.
84. Roth J, Teigelkamp S, Wilke M, Grun L, Tummler B, Sorg C: Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 1992, 186(3-4):304-314.
85. Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderkotter C, Harms E, Sorg C, Roth J: Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000, 43(3):628-637.
86. Brun JG, Haga HJ, Boe E, Kallay I, Lekven C, Berntzen HB, Fagerhol MK: Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity. J Rheumatol 1992, 19(6):859-862.
87. Lugering N, Stoll R, Schmid KW, Kucharzik T, Stein H, Burmeister G, Sorg C, Domschke W: The myeloic related protein MRP8/14 (27E10 antigen) - usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur J Clin Invest 1995, 25(9):659-664.
88. Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, Gunzer M, Frings W, Schonlau F, Roth J, Sorg C, Nacken W: Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol 2003, 23(3):1034-1043.
89. Hu SP, Harrison C, Xu K, Cornish CJ, Geczy CL: Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophages by lipopolysaccharide. Blood 1996, 87(9):3919-3928.
90. Xu K, Geczy CL: IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. J Immunol 2000, 164(9):4916-4923.
91. Yen T, Harrison CA, Devery JM, Leong S, Iismaa SE, Yoshimura T, Geczy CL: Induction of the S100 chemotactic protein, CP-10, in murine microvascular endothelial cells by proinflammatory stimuli. Blood 1997, 90(12):4812-4821.